Recent CNIC News
ARC Clean Technology and the Canadian Nuclear Isotope Council partner to bolster Canada’s Isotope Ecosystem
Toronto – December 20, 2022 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce a partnership with ARC Clean Technology (ARC). As a member of the CNIC, ARC joins 76+ organizations...
Canadian Nuclear Isotope Council: Statement Regarding the Worldwide Isotope Shortage
Toronto – November 10, 2022 – There is mounting concern in Canada and around the world that a global medical isotope shortage of Molybdenum-99 (Mo-99) is impacting patients. As a result, doctors...
AtomVie Global Radiopharma Inc. joins the CNIC to bring new leadership, innovation, and collaboration to the radiopharmaceutical industry.
Toronto – November 2, 2022 – AtomVie Global Radiopharma Inc. (AtomVie), a manufacturer and supplier of multiple finished-dose therapeutic radiopharmaceutical products, is the newest member of the...
Isotope Production System at Bruce Power commences Commercial Production of Lutetium-177
Toronto, Ontario – October 25, 2022 – Yesterday, the international partnership between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich (ITM), announced...
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced...
The CNIC joins twenty leading organizations as part of a joint Industry Statement touting the benefits of nuclear isotopes.
Toronto – August 16, 2022 – The Canadian Nuclear Isotope Council (CNIC) is proud to participate in a joint Industry Statement to the Tenth Review Conference of the Parties to the Treaty on the...
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
(OTTAWA, ON – June 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and...
Job Posting: Policy, Government and Stakeholder Relations Specialist (Hybrid) – CLOSED
THIS POSITION IS NOW FILLED Job Overview Policy, Government and Stakeholder Relations Specialist at the CNIC is responsible for connecting federal, provincial, and municipal political leaders to the...
Laurentis is helping meet global demands by increasing He-3 production
Helium-3 (He-3) is a rare isotope used in research, border security and medical imaging In a world where raw materials and supplies are under tension, Helium-3 (He-3), a rare isotope used in quantum...
Installation complete of new Isotope Production System at Bruce Power, paving way for production of life-saving medical isotopes
TIVERTON, ON – January 24, 2022 – Bruce Power and Isogen (a partnership between Kinectrics and Framatome) have completed the installation of a groundbreaking Isotope Production System (IPS), making...
Laurentis Energy Partners signs long-term commercial agreement with Air Liquide for the distribution of Helium-3
Valuable isotope used in quantum computing, neutron research, border security and medical imaging Toronto, ON – Laurentis Energy Partners today announced a long-term commercial agreement with Air...
Regulatory approval supports Laurentis’s program to produce the medical isotope Molybdenum-99 in Ontario for BWXT Medical
One of the most prevalently used diagnostic imaging agents in nuclear medicine, helping to detect illnesses like cancer and heart disease Clarington, Ontario – A new program, led by Laurentis Energy...
Ontario Isotope Motion Passes Legislature Unanimously
November 2, 2021: Today in the Ontario legislature, a Private Member’s motion introduced by Bruce-Grey-Owen Sound MPP Bill Walker passed with all party support. The motion asserted Ontario’s global...
Laurentis Energy Partners: Strengthening Canada’s isotope leadership together
TORONTO – October 27, 2021 – Laurentis Energy Partners, an innovator and leader in the clean-energy industry, has joined the Canadian Nuclear Isotope Council (CNIC). Laurentis Energy Partners offers...
A historic day for Canada’s medical isotope industry
October 26, 2021: On Oct. 21, a historic Private Member’s Bill was introduced into the Legislature by Bill Walker, MPP for Bruce-Grey-Owen Sound. The bill asserted Ontario’s global role as a leader...
New Radioisotope for Cancer Therapy: A new Collaboration to produce copper-67
SASKATOON - Iotron Medical Inc. (Iotron) and Canadian Isotope Innovations Corp. (CIIC) are pleased to announce a collaboration to produce the radioisotope copper-67 (Cu-67) for new cancer therapies....
Storied Nuclear Manufacturer, Niagara Energy Products, joins the CNIC
TORONTO – August 24, 2021 – Niagara Energy Products (NEP), a leader in the field of manufacturing radiation shielded containment vessels for isotopes and nuclear contaminated waste, has joined the...
Women in Nuclear Canada and the CNIC partner to advance awareness of the benefits of nuclear power
Women in Nuclear (WiN) Canada, an association that has been working to support the objectives of WiN Global by emphasizing and supporting the role that women can and do have in addressing public...
New partnership advances medical isotope technology
McMaster University and Promation have signed a Memorandum of Understanding (MoU) to work together to bring a new medical isotope technology developed at McMaster to the marketplace. At the center...
CNIC signs historic MOU to collaborate on the 11th International Conference on Isotopes
TORONTO – May 12 , 2021 –The Canadian Nuclear Isotope Council (CNIC) and the Local Organizing Committee of the 11th International Conference on Isotopes (11ICI) have entered into a Memorandum of...
Publications
Canada has a unique position that is recognized globally: it is the world’s largest supplier of Cobalt-60 and Iodine-125; it hosts mostly all supply chain partners within its borders; it has a long tradition in supply chain collaboration; and it is renowned around the world for developing new applications.
Isotopes: Global Importance and Opportunities for Canada
This publication highlights the important of having a continuous and reliable supply of medical isotopes accessible to the rest of the world.
Introduction to CNIC
A glance at this independent organization and its role to advocate for Canada’s role in the production of the world’s supply of isotopes.
Did You Know?
The Canadian Nuclear Safety Commission licenses the use and production of over 250 radioisotopes in Canada. And more key facts. . . .